Firefly Phototherapy Device

Target SDGs

Market Suggested Retail Price

$1,500.00

Target Users (Target Impact Group)

Small and Medium-sized Enterprises, Public Sector Agencies, NGOs

Distributors / Implementing Organizations

East Meets West Foundation through its Breath of Life program, MTTS for direct sales.

Competitive Landscape

Direct competitors include Little Sparrows Technologies Bili-Hut, D-Rev Brilliance Pro, and Brilliance Phototherapy Device.

Regions

Africa, Asia, Caribbean

Countries

Afghanistan, Benin, Burkina Faso, Burundi, Cambodia, Ghana, Indonesia, Laos, Malaysia, Mongolia, Nepal, Nigeria, Philippines, Sierra Leone, Singapore, Somalia, South Africa, Tanzania, Thailand, Timor-Leste, Uganda, Vietnam, Zimbabwe

Manufacturing/Building Method

Firefly is in full-scale manufacturing. All components of the Firefly have been designed to be mass-produced. Design that Matters has provided capacity development for Vietnamese manufacturer Medical Technology Transfer Services (MTTS) to assist with the sourcing of mass-produced plastic parts and in-house metal tube bending capabilities so that MTTS can mass-produce the Firefly ^{Interview with designer}

Intellectural Property Type

Trade Secret

User Provision Model

DtM and partners MTTS and Day One Health continue to work with individual donors, corporate sponsors, international aid groups and government agencies to distribute Firefly to hospitals and new countries and conduct user training. To date the devices have been supplied to Asia, Africa and the Caribbean region.

Distributions to Date Status

As of November 2018, the Firefly phototherapy device has treated more than 200,000 newborns in 25 countries across Africa, Asia, and the Caribbean including; Vietnam, Myanmar, Cambodia, East Timor, Thailand, Malaysia, Ghana, Jamaica, Uganda, Zimbabwe, and  Tanzania.  East Meets West, MTTS, and DtM continue to expand Firefly into new hospitals and countries, and seek out new distribution channels.

Design Specifications

Component Overview
Firefly consists of a removable bassinet made from clear scratch-resistant plastic, a fixed top light, a bottom light, and a control panel for displaying power switch, light intensity, treatment hours, and total device hours.
Key Features: No moving parts; enclosure designed toward NEMA Type 5
Dimensions (LxWxH): Overall (66 cm x 38 cm x 49.5 cm ), Top Light ( 51.6 cm x 12.5 cm x 6.3 cm), Bottom Light (64.7 cm x 38 cm x 10 cm)
Total unit mass: 11.8 kgs

Operational Overview: 2-sided light design offers top and bottom phototherapy reducing total treatment time; the portable and compact nature of Firefly allows it to be used in mother's recovery room so she can continue breastfeeding while infant receives phototherapy; single power button with single light intensity setting and fixed light distance is intended to keep the Firefly simple and to minimize the risk of using it incorrectly.

Product Schematics

Technical Support

Medical staff must be trained in proper use. MTTS provides user training through a network of consultants located in the different countries

Replacement Components

Firefly was designed with minimalism in mind with few components that could require replacement like fuses, power cables, AC plug, and Trip switch. The LED lights used are expected to last for five years with non-stop usage 24/7

Lifecycle

The Firefly has been designed for 5 years of 24/7 hour operation. Its LED lights are rated to last up to 44,000 hours before requiring replacement. In addition, Firefly has no moving parts, outer casings have tight seams and no holes in order to prevent most insects, dust and liquids from entering and damaging the device or dimming the lights.

MTTS offers a 1 year warranty  for all of the products it manufactures

Manufacturer Specified Performance Parameters

FireFly set out to develop an easy-to-use, durable, portable, and compact phototherapy device for use in resource-limited settings.

Vetted Performance Status

Firefly data from 17 infant treatments with average initial TSB 305 uMol/L (17.8 mg/dL) yielded median serum bilirubin reduction rate of -6.7 uMol/L/hr (-0.39 mg/dL/hr). Multiple linear regression of Firefly data based on study of 66 infants in 2-sided phototherapy predicts Firefly rate of -5.3 uMol/L/hr (-0.31 mg/dL/hr) given initial TSB of 265 uMol/L (15.5 mg/dL) A Clinical Evaluation of 17 infant treatments indicated Firefly reduces treatment time for a typical patient by at least 40% compared to state-of-the-art single-sided LED phototherapy. Reduced treatment time meant discharge from the highly infectious hospital environment after 20 hours on average instead of the typical 35 hours or often much longer in low-resource settings. Clinical trials continued: As of July 18, 2012, local clinical trial doctors reported 3 out of 55 infants treated with Firefly would have had to undergo an exchange blood transfusion if Firefly had not been available. A recent peer-reviewed study (Arnolda et al., PLOS One, 2018) summarizes the results of a two-year side-by-side comparison of phototherapy performance between single- and double-sided devices conducted at Danang Women and Children's Hospital in Vietnam. Compared to the GE Lullaby overhead phototherapy device, Firefly showed a 54% increase in the hourly rate of bilirubin (TSB) reduction and an overall 21% decrease in newborn treatment time.

Safety

Firefly cannot be used with overhead infant warmers due to the design (it can be used with side warmers). This means that it is better suited for use in warm climates or for treating term infants who have jaundice but can regulate their own body temperature.

Complementary Technical Systems

Eye covers; Gonad covers

Academic Research and References

Compliance with regulations

IEC 60601-1:2005: Medical Electrical Equipment - Part 1: General Requirements
for Basic Safety and Essential Performance

IEC 60601-2-50:2009: Medical Electrical Equipment - Part 2-50: Particular requirements
for the safety of infant phototherapy equipment

American Academy of Pediatrics phototherapy standard: >30 uW/cm²/nm

Evaluation methods

Rate of breakdown in Serum Bilirubin levels

Reduction in treatment and Discharge time for children with Jaundice

Other Information

None